Table of Contents Author Guidelines Submit a Manuscript
International Journal of Genomics
Volume 2013, Article ID 406217, 10 pages
http://dx.doi.org/10.1155/2013/406217
Research Article

A Bayesian Hierarchical Model for Relating Multiple SNPs within Multiple Genes to Disease Risk

Division of Biostatistics, Department of Preventive Medicine, University of Southern California (USC), 2001 N. Soto Street, Los Angeles, CA, USA

Received 30 May 2013; Revised 3 September 2013; Accepted 9 September 2013

Academic Editor: Soraya E. Gutierrez

Copyright © 2013 Lewei Duan and Duncan C. Thomas. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Bernstein, B. Langholz, R. W. Haile et al., “Study design: evaluating gene-environment interactions in the etiology of breast cancer-the WECARE study,” Breast Cancer Research, vol. 6, no. 3, pp. R199–R214, 2004. View at Google Scholar · View at Scopus
  2. B. Langholz, D. C. Thomas, M. Stovall et al., “Statistical methods for analysis of radiation effects with tumor and dose location-specific information with application to the wecare study of asynchronous contralateral breast cancer,” Biometrics, vol. 65, no. 2, pp. 599–608, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Stovall, S. A. Smith, B. M. Langholz et al., “Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study,” International Journal of Radiation Oncology Biology Physics, vol. 72, no. 4, pp. 1021–1030, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. L. Bernstein, S. Teraoka, M. C. Southey et al., “Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T > G and c.1066-6T > G (IVS10-6T > G) from the breast cancer family registry,” Human Mutation, vol. 27, no. 11, pp. 1122–1128, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Concannon, R. W. Haile, A. L. Bøorresen-Dale et al., “Variants in the ATM gene associated with a reduced risk of contralateral breast cancer,” Cancer Research, vol. 68, no. 16, pp. 6486–6491, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Langholz, J. L. Bernstein, L. Bernstein et al., “On the proposed association of the ATM variants 5557G>A and IVS38-8T>C and bilateral breast cancer,” International Journal of Cancer, vol. 119, no. 3, pp. 724–725, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. C. B. Begg, R. W. Haile, Å. Borg et al., “Variation of breast cancer risk among BRCA1/2 carriers,” Journal of the American Medical Association, vol. 299, no. 2, pp. 194–201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Borg, R. W. Haile, K. E. Malone et al., “Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study,” Human Mutation, vol. 31, no. 3, pp. E1200–E1240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Capanu, P. Concannon, R. W. Haile et al., “Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling,” Genetic Epidemiology, vol. 35, no. 5, pp. 389–397, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. C. Figueiredo, J. D. Brooks, D. V. Conti et al., “Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status,” Breast Cancer Research and Treatment, vol. 127, no. 3, pp. 819–829, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Quintana, J. L. Berstein, D. C. Thomas, and D. V. Conti, “Incorporating model uncertainty in detecting rare variants: the Bayesian risk index,” Genetic Epidemiology, vol. 35, no. 7, pp. 638–649, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. M. A. Quintana, F. R. Schumacher, G. Casey, J. L. Bernstein, L. Li, and D. V. Conti, “Incorporating prior biologic information for high-dimensional rare variant association studies,” Human Heredity, vol. 74, pp. 184–195, 2012. View at Publisher · View at Google Scholar
  13. L. Mellemkjær, C. Dahl, J. H. Olsen et al., “Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study,” British Journal of Cancer, vol. 98, no. 4, pp. 728–733, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. L. Bernstein, R. W. Haile, M. Stovall et al., “Radiation exposure, the ATM gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study,” Journal of the National Cancer Institute, vol. 102, no. 7, pp. 475–483, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. J. L. Bernstein, D. C. Thomas, R. E. Shore et al., “Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report,” European Journal of Cancer, vol. 49, no. 14, pp. 2979–2985, 2013. View at Publisher · View at Google Scholar
  16. J. N. Poynter, B. Langholz, J. Largent et al., “Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study,” Cancer Causes and Control, vol. 21, no. 6, pp. 839–846, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. K. W. Reding, J. L. Bernstein, B. M. Langholz et al., “Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer,” Breast Cancer Research and Treatment, vol. 123, no. 2, pp. 491–498, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Wang, M. Li, and M. Bucan, “Pathway-based approaches for analysis of genomewide association studies,” American Journal of Human Genetics, vol. 81, no. 6, pp. 1278–1283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Thomas, “Methods for investigating gene-environment interactions in candidate pathway and genome-wide association studies,” Annual Review of Public Health, vol. 31, pp. 21–36, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Thomas, “Gene-environment-wide association studies: emerging approaches,” Nature Reviews Genetics, vol. 11, no. 4, pp. 259–272, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Basu and W. Pan, “Comparison of statistical tests for disease association with rare variants,” Genetic Epidemiology, vol. 35, no. 7, pp. 606–619, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. Quintana and D. V. Conti, “Integrative variable selection via Bayesian model uncertainty,” Statistics in Medicine, 2013. View at Publisher · View at Google Scholar
  23. T. J. Hoffmann, N. J. Marini, and J. S. Witte, “Comprehensive approach to analyzing rare genetic variants,” PLoS ONE, vol. 5, no. 11, Article ID e13584, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. L. S. Chen, C. M. Hutter, J. D. Potter et al., “Insights into colon cancer etiology via a regularized approach to gene set analysis of GWAS data,” American Journal of Human Genetics, vol. 86, no. 6, pp. 860–871, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. J. D. Brooks, S. N. Teraoka, A. S. Reiner et al., “Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study,” Human Mutation, vol. 33, no. 1, pp. 158–164, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. Gene Ontology Consortium, “The Gene Ontology in 2010: extensions and refinements,” Nucleic Acids Research, vol. 38, supplement 1, pp. 331–335, 2010. View at Publisher · View at Google Scholar
  27. R. Kass and A. Raftery, “Bayes factors,” Journal of the American Statistical Association, vol. 90, no. 430, pp. 773–795, 1995. View at Publisher · View at Google Scholar
  28. P. Concannon, R. W. Haile, A. L. Bøorresen-Dale et al., “Variants in the ATM gene associated with a reduced risk of contralateral breast cancer,” Cancer Research, vol. 68, no. 16, pp. 6486–6491, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. A. C. Antoniou, O. M. Sinilnikova, J. Simard et al., “RAD51 135 G→C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies,” American Journal of Human Genetics, vol. 81, no. 6, pp. 1186–1200, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. A. C. Antoniou, O. M. Sinilnikova, J. Simard et al., “RAD51 135 G→C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies,” American Journal of Human Genetics, vol. 81, no. 6, pp. 1186–1200, 2007. View at Publisher · View at Google Scholar
  31. K. D. Yu, C. Yang, L. Fan, A. X. Chen, and Z. M. Shao, “RAD51 135 G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies,” Breast Cancer Research and Treatment, vol. 126, no. 2, pp. 365–371, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. P. C. Ng and S. Henikoff, “SIFT: predicting amino acid changes that affect protein function,” Nucleic Acids Research, vol. 31, no. 13, pp. 3812–3814, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Xi, I. M. Jones, and H. W. Mohrenweiser, “Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function,” Genomics, vol. 83, no. 6, pp. 970–979, 2004. View at Publisher · View at Google Scholar · View at Scopus